肾血管平滑肌脂肪瘤谱系及其影像-病理对照
本文综述肾血管平滑肌脂肪瘤(AML)的影像与病理相关性。AML由血管、平滑肌和脂肪组成,属血管周上皮样细胞肿瘤。多数为经典AML(含脂肪),乏脂肪AML以平滑肌为主,影像表现随平滑肌含量变化。罕见组织学变异包括上皮样AML和伴上皮囊肿的AML。最重要并发症为肿瘤出血,常见于大肿瘤或动脉瘤≥5 mm者,可致腹膜后出血和休克。上皮样AML可具侵袭性。治疗包括观察、栓塞、消融、手术切除或系统治疗。
要点
- 经典AML含脂肪,影像易诊断;乏脂肪AML以平滑肌为主,平扫CT呈高密度、T2低信号、明显强化。
- 肿瘤出血是最重要并发症,多见于大肿瘤或动脉瘤≥5 mm者,可致腹膜后出血和休克。
- 良性AML可侵犯肾静脉和下腔静脉;上皮样AML可局部复发和转移,行为具侵袭性。
核心结论
- AML的影像表现与病理成分密切相关,脂肪含量决定经典AML诊断,平滑肌含量驱动乏脂肪AML的影像特征。
- 大多数AML呈良性临床行为,但肿瘤出血是重要并发症,大肿瘤或动脉瘤≥5 mm者出血风险更高。
- 上皮样AML可表现侵袭性,出现局部复发和转移。
研究设计与样本
- 本文为综述,基于文献总结肾血管平滑肌脂肪瘤的影像与病理相关性,原文未报告系统检索范围与纳入文献数量。
关键影像表现/征象
- 经典AML含脂肪,绝大多数AML可检出脂肪。
- 乏脂肪AML以平滑肌为主,平扫CT呈较高密度,T2WI呈低信号,增强后明显强化。
- 罕见组织学变异包括上皮样AML和伴上皮囊肿的AML。
- 良性AML可侵犯肾静脉和下腔静脉。
诊断标准与关键数值
- 肿瘤出血最常见于大肿瘤或动脉瘤直径等于或大于5 mm的肿瘤。
临床应用与阅片要点
- 阅片时注意评估肿瘤大小和有无动脉瘤,动脉瘤≥5 mm提示出血风险增加。
- 乏脂肪AML需结合平扫CT高密度、T2低信号和明显强化与肾细胞癌鉴别。
- 发现肾静脉或下腔静脉侵犯时,需考虑良性AML可能,避免误判为恶性。
- 上皮样AML可局部复发和转移,影像随访需关注侵袭性表现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Angiomyolipoma (AML) is a benign tumor comprised of a mixture of vessels ("angio"), smooth muscle ("myo"), and adipose tissue ("lipo"). It belongs to a group of unusual mesenchymal tumors with myogenic and melanocytic differentiation known as perivascular epithelioid cell tumors. AMLs are commonly sporadic tumors but may be associated with tuberous sclerosis complex (TSC) and/or lymphangioleiomyomatosis (LAM). The imaging appearance of AMLs strongly correlates with the pathologic findings. Fat is detectable in the vast majority of AMLs, and these tumors are referred to as classic AMLs. Fat-poor AMLs are smooth muscle-predominant tumors. The smooth muscle content drives the imaging findings, which include increased attenuation on non-contrast-enhanced CT images, low T2 signal intensity, and avid enhancement. Rare histologic variants of AMLs include epithelioid AML (EAML) and AML with epithelial cysts. Most AMLs exhibit benign clinical behavior. The most important clinical complication of AML is tumor hemorrhage, which may lead to retroperitoneal hemorrhage and shock. Hemorrhage most commonly occurs in large tumors or tumors with aneurysms equal to or larger than 5 mm. Benign AMLs may also invade the renal vein and inferior vena cava. EAMLs may behave aggressively with local recurrence and metastatic spread. Treatment options for AML vary and may include observation for small classic AMLs; embolization, ablation, and/or surgical resection of large or potentially aggressive lesions; or systemic therapy in cases associated with TSC or LAM. ©RSNA, 2025 Supplemental material is available for this article.
引用
- Lubner MG, Marko J, Taffel MT, et al. Spectrum of Renal Angiomyolipoma with Radiologic-Pathologic Correlation. Radiographics. 2025. PMID: 40504730. doi:10.1148/rg.240159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。